Topical Calcineurin Inhibitors and Skin Cancer-Another Piece of the Puzzle

JAMA Dermatol. 2020 Oct 1;156(10):1053-1054. doi: 10.1001/jamadermatol.2020.2239.

Authors

Aaron M Drucker^{1

2}, Mina Tadrous^{2

3}

Affiliations

¹ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
² Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
³ Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.

PMID: 32785627
DOI: 10.1001/jamadermatol.2020.2239

No abstract available

Publication types

Editorial
Comment

MeSH terms

Administration, Topical
Adult
Calcineurin Inhibitors / therapeutic use
Carcinoma*
Dermatitis, Atopic* / drug therapy
Humans
Keratinocytes
Skin Neoplasms*
Tacrolimus / therapeutic use

Substances

Calcineurin Inhibitors
Tacrolimus